Evidence map›Paper›PMID 42884673›Full record

ReviewNutrients2026

Riboflavin as a Regulator of Cellular Metabolism: From the Classic Vitamin B2 to a Key Redox Factor.

Julia Kaźmierczak-Barańska, Krzysztof Halczuk, Bolesław T Karwowski

Abstract readReview
In one paragraph

Review in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Julia Kaźmierczak-BarańskaDNA Damage Laboratory, Food Science Department, Faculty of Pharmacy, Medical University of Lodz, ul. Muszynskiego 1, 90-151 Lodz, Poland.ORCID 0000-0001-8560-5727
Krzysztof HalczukDNA Damage Laboratory, Food Science Department, Faculty of Pharmacy, Medical University of Lodz, ul. Muszynskiego 1, 90-151 Lodz, Poland.ORCID 0000-0003-1709-5897
Bolesław T KarwowskiDNA Damage Laboratory, Food Science Department, Faculty of Pharmacy, Medical University of Lodz, ul. Muszynskiego 1, 90-151 Lodz, Poland.ORCID 0000-0001-6922-7834

Funding

Medical University of Lodz 503/3-045-02/503-31-001
6 · The paper itself

Abstract

Riboflavin, i.e., vitamin B2, was first isolated by Kuhn and Győrgy in 1933, who reported that it acts as a growth factor. Riboflavin has long been known to play a key role in energy metabolism and cellular respiration, and its deficiency negatively affects skin and mucous membrane health. More recent studies have found it to regulate mitochondrial metabolism and to serve as the core of flavin coenzymes (FAD, FMN), which enable the respiratory chain and β-oxidation. Riboflavin also plays a key role as an antioxidant. While it is not a classic free antioxidant, it supports the enzymatic antioxidant system by supporting glutathione reductase, thioredoxin reductase, and ROS neutralization. On the other hand, when exposed to light, riboflavin exhibits photosensitizing properties that generate reactive oxygen species. As a result, it can initiate oxidative processes involving lipids, proteins, and nucleic acids, thereby exhibiting a prooxidative effect. The aim of this review is to provide an overview of the current understanding of the role of riboflavin in cellular and human health.

Indexed as

AntioxidantsRiboflavinAnimalsEnergy MetabolismHumansMitochondriaOxidation-ReductionOxidative StressReactive Oxygen SpeciesAntioxidantsReactive Oxygen SpeciesRiboflavinantioxidationhuman healthprooxidationriboflavin

Identifiers

PMID42884673
PMCPMC13666795

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.